<div id="readability-page-1" class="page"><div>China's Hansoh Pharmaceutical Group is raising HK$4.68 billion ($600 million) from a seven-year zero-coupon convertible bond, a term sheet seen by Reuters on Monday showed.The Hong Kong dollar-denominated bonds, due in 2033, have a 0% yield to maturity and are convertible at a premium of around 47% to 52% over the reference share price, set at the clearing price of a concurrent delta placement, the sheet showed.They carry put options in the third and fifth years at par.Proceeds will be used for research and development, construction of manufacturing facilities and general corporate purposes, the term sheet showed.Hansoh is a drugmaker focused on the research, development and manufacturing of medicines, with an emphasis on oncology, infectious diseases, central nervous system, metabolic and autoimmune disorders, its official website says.Hansoh shares have risen 11.5% this year, LSEG data showed.Morgan Stanley and Citigroup are joint global coordinators and joint bookrunners, the term sheet showed. </div></div>

China’s Hansoh Pharmaceutical Group is raising $600 million through a seven-year zero-coupon convertible bond. The bonds, due in 2033, have a 0% yield and are convertible at a premium of 47% to 52% over the reference share price. Proceeds will fund research, manufacturing facilities, and corporate purposes. Hansoh focuses on developing medicines for various diseases. Shares have increased by 11.5% this year. Morgan Stanley and Citigroup are the joint global coordinators for this bond issuance.

Reuters

E Fund CSI 300 Health Care ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

China Merchants CSI Biotechnology Theme ETF

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)

Bosera Hang Seng Health Care ETF(QDII)

Hwabao WP CSI Pharmaceuticals ETF

JYPC

ChinaAMC SSE STAR Biology and Medicine ETF

Pharscin Pharma

ChinaAMC CSI Biotechnology Theme ETF

Yinhua CSI Innovative Drugs Industry ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

ChinaAMC SSE Health Care ETF Initiating Fund

HANSOH PHARMA

E Fund CSI Biotechnology Theme ETF

China Universal CNI HK Connect Innovative Drugs Industry ETF

Penghua CSI HK Connect Health Care Composite ETF

Minsheng Royal CSI Biotechnology Theme ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

China's Hansoh Pharmaceutical launches $600 million convertible bond, term sheet shows